HER2 Aberrations in NSCLC: So Close Yet So Far-Reference-Cited by-同舟云学术

HER2 Aberrations in NSCLC: So Close Yet So Far

Published:2020-11 Issue:4 Volume: Page:1049-1051
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Sartori Giulia¹,Belluomini Lorenzo¹,Trovato Rosalinda¹,Minari Roberta¹,Caliò Anna¹,Ugel Stefano¹,Milella Michele¹,Pilotto Sara¹

Affiliation:

1. Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00195

Reference10 articles.

1. Targeting HER2 Alterations in Non–Small-Cell Lung Cancer: A Comprehensive Review

2. Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate

3. ERBB2 -Mutated Metastatic Non–Small Cell Lung Cancer: Response and Resistance to Targeted Therapies

4. Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort

5. Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to G. Sartori et al;JCO Precision Oncology;2020-11